(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EMMYON

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EMMYON

ST13

US500000087590425

Class

42

Filing

87590425

Registration

5474009

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

12/19/2023

Trademark type

Word

Nice classes

42

Filing date

08/30/2017

Registration date

05/22/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/19/2023

Last transaction

12/19/2023

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

01/01/2013

First use in commerce

01/01/2013

Drawing code

4

Owner type

03

Owner location

Rochester, MN

Examiner

PEREZ, STEVEN

Law office

L10

Current location

TMEG LAW OFFICE 101

Holders and representatives

Holders

Emmyon, Inc.
Emmyon, Inc.

Representatives

Erica M. Hines HESLIN ROTHENBERG FARLEY & MESITI P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Biotechnology research; Research and development in the chemicalnutraceuticalpharmaceutical and biotechnology fields; Research and development of pharmaceuticalsdiagnostics and therapeutics; Research and development of naturalpharmaceuticalother chemical compounds for the treatment of conditionsdiseasesdisorders; Research and development of naturalpharmaceuticalother chemical compounds that improve muscle growthmuscle massstrengthexercise capacitymetabolismgeneral nutritionagingobesity; Research and development of naturalpharmaceuticalother chemical compounds that treat muscle atrophy or diabetes; Consulting services relating to new product research and development in the fields of biotechnologychemicalsnutraceuticalspharmaceuticalsanimal testinglaboratory testingdiagnosticspharmacogenetics

Publications

History of USPTO decisions and trademark events.

19 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/19/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/19/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/19/2023

E815

TEAS SECTION 8 & 15 RECEIVED

06/23/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/22/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/22/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/06/2018

PUBO

PUBLISHED FOR OPPOSITION

03/06/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/14/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/23/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/23/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/22/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/22/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/13/2017

GNRT

NON-FINAL ACTION E-MAILED

12/13/2017

CNRT

NON-FINAL ACTION WRITTEN

12/13/2017

DOCK

ASSIGNED TO EXAMINER

12/05/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/07/2017

NWAP

NEW APPLICATION ENTERED

09/02/2017

Continuous trademark protection

Get notified about every new filing that threatens EMMYON or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.